CX3CL1 and hepatocellular carcinoma: In vivo study showed that injection of CX3CL1+NK following HCC cells resulted in significantly decreased pulmonary metastasis compared HCC cells with injection of CX3CR1-NK cells (1/10 vs 6/10) (P<0.05, Figure 6G).